LOGC
Nuveen Asset Management’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-34,958
| Closed | -$254K | – | 3500 |
|
|
2021
Q1 | $254K | Buy |
34,958
+3,668
| +12% | +$26.7K | ﹤0.01% | 3199 |
|
|
2020
Q4 | $239K | Buy |
31,290
+1,672
| +6% | +$12.8K | ﹤0.01% | 3179 |
|
|
2020
Q3 | $269K | Buy |
29,618
+472
| +2% | +$4.29K | ﹤0.01% | 3106 |
|
|
2020
Q2 | $246K | Buy |
29,146
+10,428
| +56% | +$88K | ﹤0.01% | 3063 |
|
|
2020
Q1 | $92K | Hold |
18,718
| – | – | ﹤0.01% | 3067 |
|
|
2019
Q4 | $135K | Hold |
18,718
| – | – | ﹤0.01% | 3106 |
|
|
2019
Q3 | $202K | Hold |
18,718
| – | – | ﹤0.01% | 3122 |
|
|
2019
Q2 | $243K | Buy |
+18,718
| New | +$243K | ﹤0.01% | 3139 |
|